Iridex (IRIX) Capital Expenditures (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -4.72% |
| Jan 3, 2026 | 715.38% |
| Sep 27, 2025 | 0.00% |
| Jun 28, 2025 | 18.18% |
| Mar 29, 2025 | 22.22% |
| Dec 28, 2024 | 800.00% |
| Mar 30, 2024 | 109.38% |
| Dec 30, 2023 | -139.02% |
| Sep 30, 2023 | 412.50% |
| Jul 1, 2023 | -62.79% |
| Apr 1, 2023 | -48.19% |
| Dec 31, 2022 | 45.61% |
| Oct 1, 2022 | -52.50% |
| Jul 2, 2022 | 361.54% |
| Apr 2, 2022 | -79.37% |
| Sep 26, 2020 | -27.27% |
| Jun 27, 2020 | -83.82% |
| Mar 28, 2020 | 2,166.67% |
| Dec 28, 2019 | -78.57% |
| Sep 28, 2019 | -68.18% |
| Jun 29, 2019 | -34.33% |
| Mar 30, 2019 | 36.73% |
| Dec 29, 2018 | 188.24% |
| Sep 29, 2018 | -83.00% |
| Jun 30, 2018 | -63.50% |
| Mar 31, 2018 | 730.30% |
| Dec 30, 2017 | -68.87% |
| Sep 30, 2017 | 11.58% |
| Jul 1, 2017 | -72.14% |
| Apr 1, 2017 | 26.30% |
| Dec 31, 2016 | -36.47% |
| Oct 1, 2016 | 52.88% |
| Jul 2, 2016 | 212.36% |
| Apr 2, 2016 | -77.92% |
| Sep 27, 2014 | -45.76% |
| Jun 28, 2014 | 118.52% |
| Mar 29, 2014 | -25.52% |
| Dec 28, 2013 | -11.04% |
| Sep 28, 2013 | 201.85% |
| Jun 29, 2013 | 200.00% |
| Mar 30, 2013 | -78.57% |
| Dec 29, 2012 | -38.24% |
| Sep 29, 2012 | 156.60% |
| Jun 30, 2012 | -56.20% |
| Mar 31, 2012 | 92.06% |
| Dec 31, 2011 | -39.42% |